ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669158 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669158; 2) Community: the network communities that were significantly associated with the response to NSC 669158; 3) Molecule: the relationships between components within communities and NSC 669158; 4) MDR: the compounds that were significantly associated with the NSC 669158.

NSC Compound Enrichment Correlation
NSC 762009 Copper(II) complex with quin as a ligand 0.0283958753782624 0.52636908
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0283958753782624 -0.070798926
NSC 87500 Solacongestidine 0.0283958753782624 0.049446076
NSC 19441 FDA 0283 0.0287230216965525 -0.0098108979
NSC 348402 Null 0.0287230216965525 0.57757595
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.0287230216965525 -0.11081589
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0287230216965525 0.083686944
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.0287230216965525 0.30888839
NSC 5355 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) 0.0287230216965525 -0.026219373
NSC 642407 Null 0.0287230216965525 0.078129453
Total:102  Current:66    [First] [Prev] [Next] [Last]